Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anika Therapeutics
(NQ:
ANIK
)
16.97
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Anika Therapeutics
< Previous
1
2
Next >
Anika To Participate in December 2024 Investor Conferences
November 22, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024
Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via
ACCESSWIRE
Anika to Participate in the Sidoti Virtual Investor Conference
August 05, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 08, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 27, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
February 13, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
November 28, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in Upcoming Investor Conferences
November 07, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 10, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
September 19, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
September 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
August 17, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 20, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
July 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
May 30, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 19, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
